We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
AUM
$558M
AUM Growth
+$80.9M
Cap. Flow
+$74.9M
Cap. Flow %
13.41%
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$3.2M
2
BA icon
Boeing
BA
+$2.64M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.42M
4
AMGN icon
Amgen
AMGN
+$2.03M
5
ELV icon
Elevance Health
ELV
+$1.97M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.64M
2
LMT icon
Lockheed Martin
LMT
+$2.31M
3
CI icon
Cigna
CI
+$2.21M
4
WFC icon
Wells Fargo
WFC
+$2.18M
5
PAYX icon
Paychex
PAYX
+$1.89M

Sector Composition

Rank Sector Weight
1 Technology 17.12%
2 Healthcare 15.64%
3 Consumer Discretionary 14.34%
4 Industrials 14.21%
5 Financials 12.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSGS
301
DELISTED
CSG Systems International
CSGS
$565K 0.1%
10,715
+4,120
+62% +$210K
BLBD icon
302
Blue Bird Corp
BLBD
$2.41B
$564K 0.1%
+25,105
New +$537K
MDT icon
303
Medtronic
MDT
$107B
$563K 0.1%
+6,387
New +$550K
HAE icon
304
Haemonetics
HAE
$3.58B
$562K 0.1%
6,600
+3,001
+83% +$254K
OMCL icon
305
Omnicell
OMCL
$1.86B
$560K 0.1%
+7,605
New +$513K
TK icon
306
Teekay
TK
$975M
$556K 0.1%
92,019
-39,592
-30% -$231K
CE icon
307
Celanese
CE
$5.09B
$554K 0.1%
+4,781
New +$518K
CCCC icon
308
C4 Therapeutics
CCCC
$376M
$553K 0.1%
201,033
+167,194
+494% +$537K
ROK icon
309
Rockwell Automation
ROK
$51.4B
$553K 0.1%
+1,678
New +$485K
COLM icon
310
Columbia Sportswear
COLM
$3.19B
$552K 0.1%
7,149
+2,985
+72% +$240K
IMUX icon
311
Immunic
IMUX
$182M
$551K 0.1%
21,945
+14,868
+210% +$249K
CRUS icon
312
Cirrus Logic
CRUS
$6.74B
$550K 0.1%
6,784
+3,533
+109% +$292K
UBS icon
313
UBS Group
UBS
$170B
$548K 0.1%
+27,027
New +$543K
AEL
314
DELISTED
American Equity Investment Life Holding Company
AEL
$547K 0.1%
+10,495
New +$422K
PPG icon
315
PPG Industries
PPG
$25.9B
$546K 0.1%
+3,683
New +$514K
AZPN
316
DELISTED
Aspen Technology Inc
AZPN
$545K 0.1%
+3,249
New +$603K
ALLE icon
317
Allegion
ALLE
$13B
$544K 0.1%
4,534
-3,108
-41% -$339K
NJR icon
318
New Jersey Resources
NJR
$6.06B
$543K 0.1%
11,503
+2,029
+21% +$102K
KRC icon
319
Kilroy Realty
KRC
$4.58B
$543K 0.1%
+18,036
New +$526K
CIEN icon
320
Ciena
CIEN
$55.3B
$543K 0.1%
12,772
+5,212
+69% +$237K
SNV
321
DELISTED
Synovus
SNV
$542K 0.1%
+17,931
New +$524K
BBWI icon
322
Bath & Body Works
BBWI
$4.01B
$542K 0.1%
14,440
+6,067
+72% +$222K
SMPL icon
323
Simply Good Foods
SMPL
$904M
$541K 0.1%
14,793
+8,334
+129% +$307K
IRWD icon
324
Ironwood Pharmaceuticals
IRWD
$611M
$539K 0.1%
+50,651
New +$544K
DINO icon
325
HF Sinclair
DINO
$15.9B
$538K 0.1%
12,071
+600
+5% +$26.1K

Similar funds

XTX Topco's Q2 2023 Portfolio in Review

As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.

  • XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
  • XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
  • XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
  • XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
  • XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
  • XTX Topco opened 778 new positions and closed 643 in Q2 2023.
  • XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.

Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.